Click
here to close Hello! We notice that
you are using Internet Explorer, which is not supported by Echinobase
and may cause the site to display incorrectly. We suggest using a
current version of Chrome,
FireFox,
or Safari.
Abstract
This article summarizes developments attained in oral vaccine formulations based on the encapsulation of antigen proteins inside porous silica matrices. These vaccine vehicles show great efficacy in protecting the proteins from the harsh acidic stomach medium, allowing the Peyer's patches in the small intestine to be reached and consequently enhancing immunity. Focusing on the pioneering research conducted at the Butantan Institute in Brazil, the optimization of the antigen encapsulation yield is reported, as well as their distribution inside the meso- and macroporous network of the porous silica. As the development of vaccines requires proper inclusion of antigens in the antibody cells, X-ray crystallography is one of the most commonly used techniques to unveil the structure of antibody-combining sites with protein antigens. Thus structural characterization and modelling of pure antigen structures, showing different dimensions, as well as their complexes, such as silica with encapsulated hepatitis B virus-like particles and diphtheria anatoxin, were performed using small-angle X-ray scattering, X-ray absorption spectroscopy, X-ray phase contrast tomography, and neutron and X-ray imaging. By combining crystallography with dynamic light scattering and transmission electron microscopy, a clearer picture of the proposed vaccine complexes is shown. Additionally, the stability of the immunogenic complex at different pH values and temperatures was checked and the efficacy of the proposed oral immunogenic complex was demonstrated. The latter was obtained by comparing the antibodies in mice with variable high and low antibody responses.
Calderón,
Polymeric soft nanocarriers as smart drug delivery systems: State-of-the-art and future perspectives.
2015, Pubmed
Calderón,
Polymeric soft nanocarriers as smart drug delivery systems: State-of-the-art and future perspectives.
2015,
Pubmed
Carvalho,
Immunological parameters related to the adjuvant effect of the ordered mesoporous silica SBA-15.
2010,
Pubmed
Chen,
The toxicity of silica nanoparticles to the immune system.
2018,
Pubmed
Coria,
Oral co-administration of a bacterial protease inhibitor in the vaccine formulation increases antigen delivery at the intestinal epithelial barrier.
2019,
Pubmed
Dobrovolskaia,
Evaluation of nanoparticle immunotoxicity.
2009,
Pubmed
Gennari,
Effect of silica on the genetic regulation of antibody responsiveness.
1987,
Pubmed
Goffin,
Oral Vaccination with Replication-Competent Adenovirus in Mice Reveals Dissemination of the Viral Vaccine beyond the Gastrointestinal Tract.
2019,
Pubmed
He,
In vivo biodistribution and urinary excretion of mesoporous silica nanoparticles: effects of particle size and PEGylation.
2011,
Pubmed
Jiang,
Targeting ideal oral vaccine vectors based on probiotics: a systematical view.
2019,
Pubmed
Kupferschmidt,
In vivo oral toxicological evaluation of mesoporous silica particles.
2013,
Pubmed
Liangjiao,
The current understanding of immunotoxicity induced by silica nanoparticles.
2019,
Pubmed
Lopes,
Antigenic and physicochemical characterization of Hepatitis B surface protein under extreme temperature and pH conditions.
2019,
Pubmed
Mercuri,
Ordered mesoporous silica SBA-15: a new effective adjuvant to induce antibody response.
2006,
Pubmed
Miquel-Clopés,
Mucosal vaccines and technology.
2019,
Pubmed
Mirchamsy,
Adjuvanticity of pGPL-Mc and LRS in the immune responses of monkeys to oral immunization with diphtheria and tetanus toxoids.
1997,
Pubmed
Mody,
Mesoporous silica nanoparticles as antigen carriers and adjuvants for vaccine delivery.
2013,
Pubmed
Rasmussen,
3D visualisation of hepatitis B vaccine in the oral delivery vehicle SBA-15.
2019,
Pubmed
Scaramuzzi,
Nanostructured SBA-15 silica as an adjuvant in immunizations with hepatitis B vaccine.
2011,
Pubmed
Scaramuzzi,
Nanostructured SBA-15 silica: An effective protective vehicle to oral hepatitis B vaccine immunization.
2016,
Pubmed
Vallhov,
Mesoporous silica particles induce size dependent effects on human dendritic cells.
2007,
Pubmed
Zhang,
Effect of vaccine administration modality on immunogenicity and efficacy.
2015,
Pubmed
Zhao,
Triblock copolymer syntheses of mesoporous silica with periodic 50 to 300 angstrom pores.
1998,
Pubmed
Zhao,
Nanoparticle vaccines.
2014,
Pubmed
